Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an ...

Amgen Inc. (NASDAQ:AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street ...

The Amgen stock price suffered a harsh reversal in the fourth quarter of 2024 as its weight loss drug failed to excite. After peaking at $341 in July, the stock plunged by over 25% to the current ...

View the latest Amgen Inc. (AMG) stock price, news, historical charts, analyst ratings and financial information from WSJ.

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Our dashboard How Low Can Amgen Stock Go In A Market Crash? dives into historical performance across market crashes. Inflation Shock (2022) AMGN dropped 26.7% from $292.39 (8 Nov 2022) to $214.27 ...

Access Amgen stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Investing.com - BMO Capital maintained its Outperform rating and $346.00 price target on Amgen (NASDAQ: AMGN) stock Tuesday following the release of Phase 1 MariTide clinical trial data.According ...

On May 1, Amgen reported a solid set of quarterly results. Q1 non-GAAP EPS of $4.90 topped the Wall Street consensus forecast by $0.64, while $8.1 billion of revenue, a 9% YoY increase, was a ...